Background: Details of the comparisons between airway and peripheral blood regulatory T cells (Tregs) in patients with atopic asthma are still unclear. The objective of this study is to investigate the profiles of both airway and circulating Tregs in atopic asthma.
INTRODUCTION
It is known that forkhead box P3 (Foxp3)-positive regulatory T cells (Tregs) are potent mediators of dominant self-tolerance. 1 Tregs have the potential to suppress both Th1-and Th2-induced inflammation. 2, 3 Activation and expansion of Tregs may be exploited for treatment of immunologic diseases such as allergic asthma. 4 Cytotoxic T-lymphocyte antigen 4 (CTLA4) is a homolog of CD28, which is expressed only on activated T cells, and binds to the accessory molecules B7-1 (CD80) and B7-2 (CD86). 5, 6 CTLA4 + CD4 + CD25 + T cells also have the characteristics of Tregs that down-regulate Th1 and Th2 responses though CTLA4 signaling. 7 It is well known that CTLA4 express both surface and cytoplasm on cells. The surface CTLA4 expressing on T cells have immunosuppressive effects. 8, 9 Surface CTLA4 also play as a sequester for B7 molecules without cytoplasmic CTLA4 and the sequestration is regulated by the levels of surface expression of CTLA-4. 10 We have already demonstrated that in patients with atopic asthma, allergen inhalation challenge induces an immediate reduction in the frequency of surface, but not intracellular, expressed CTLA4 + CD4 + CD25 + cells in induced sputum from subjects who develop allergen-induced isolated early responses, and that this returns to the baseline within 24 h. In contrast, subjects who develop allergen-induced dual responses have lower baseline levels of these cells, which do not change after inhaled allergen challenge, 11 and the number of such cells in induced sputum increases after treatment with inhaled corticosteroids. 12 Provoost and coworkers 13 have demonstrated that peripheral Tregs are decreased in asthmatics. In addition, a study of asthmatic children has demonstrated that Tregs in bronchoalveolar lavage fluid (BALF) are decreased in comparison with control children. 14 Conversely , it has been reported that Tregs in BALF are increased in adults with asthma, and even mild asthma, relative to healthy controls. 15 Also, a previous study has demonstrated that Tregs were more numerous in BALF after allergen provocation than before challenge. 16 CD 25 + CD 4 + cells have two phenotypes : CD25 high CD4 + cells and CD25 low CD4 + cells. CD25 high CD4 + cells have immunosuppressive functions, whereas CD25 low CD4 + cells are activated effector or memory T cells that lack the immunosuppressive functions as Tregs. 17, 18 In this study, to investigate the profiles and roles of all three Treg phenotypes in atopic asthma, we have compared the relative frequencies of intracellular Foxp3 + (Foxp3 + ), surface CTLA4 + (CTLA4 + ), and Foxp3 + CTLA4 + cells among CD25 high CD4 + and CD25 low CD4 + cells in induced sputum and peripheral blood, in steroid-naïve, non-smoking patients with mild atopic asthma, with the frequencies in non-atopic healthy subjects (con-trols), and examined the correlations between each phenotype and eosinophilic inflammation, lung function, and airway hyperresponsiveness (AHR) in asthmatics.
METHODS

SUBJECTS
Twenty-eight non-smoking patients with stable, mild atopic asthma [female : male = 10 : 18, age range 24 to 45 yr] and 18 non-smoking, non-atopic, and ageand sex-matched controls [female : male = 6 : 12, age range 27 to 43 yr] were enrolled ( Table 1 ). All of the asthmatics were steroid-naïve and had used only short-acting β2-agonists (SABA) intermittently for treatment of their asthma. None of them had used SABA, inhaled or systemic corticosteroids, longacting β2-agonists (LABA), leukotriene receptor antagonists (LTRA), theophylline, anti-histamines, or anti-IgE antibody for at least 4 weeks prior to the study. None of the subjects had received allergen immunotherapy. Patients were excluded had suffered asthmatic exacerbations or airway infections during the previous 4 weeks. Diagnosis of asthma and its severity was based on the Global Initiative for Asthma (GINA) guidelines. 19 
STUDY PROTOCOL
Each subject underwent a medical interview and examination, chest radiography, electrocardiography, and spirometry training at the screening visit (visit 1). Blood tests, spirometry, AHR to methacholine (MCh), and sputum induction were conducted at between 8:00 and 9:00 am on visit 2 within 14 days after visit 1. Atopy was identified from the values of serum total IgE (cut-off value for atopy >250 IU! L) and levels of IgE against several specific allergens (Dermatophagoides farina, Dermatophagoides pteronyssinus, house dust mite, Candida spp., Aspergillus spp., and Japanese cedar pollen) determined using commercial kits (DPC-Immulyze Total IgE III and Immulize 2000 , Mitsubishi Kagaku Iatron, Tokyo, Japan). Atopy was diagnosed from the patient's history of atopic diseases and symptoms, a total IgE level of >250 IU! L, and! or positive results for IgE against the specific allergens.
The study was performed in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Approval (No. 10089) was obtained from the regulatory agency and human ethics committee of Kurume University, Japan, and all the patients provided written informed consent.
SPIROMETRY
Spirometry was performed as previously reported 20, 21 and repeated 3 times, the best value being adopted. Subjects were required to have a forced expiratory volume in 1 second (FEV1) of greater than 80% of the predicted value. AHR was expressed as PC20 MCh Patients were excluded had suffered asthmatic exacerbations or airway infections during the previous 4 weeks. Diagnosis of asthma and its severity was based on the Global Initiative for Asthma guidelines. 16 All data were expressed as mean ± SEM. Data were compared using Fisher's Exact test. Geometric means ± GSEM. FEV1, forced expiratory volume in 1 second; PC20, provocative concentration of MCh causing a 20% fall in FEV1; MCh, methacholine; Eos, eosinophils; NS, not signifi cant.
(the provocative concentration of MCh causing a 20% fall in FEV1). The predicted values were calculated using the formula for Japanese. 21
MCh INHALATION CHALLENGE
The MCh inhalation challenge was performed using the method described by Cockcroft and colleagues. 22 Briefly, subjects inhaled through a mouthpiece attached to an ultrasonic nebulizer. Normal saline, followed by doubling concentrations of MCh, were nebulized and supplied for 2 minutes each. FEV1 was measured at 30, 90, 180, and 300 s after each inhalation using an electronic spirometer (Chestgraph Jr HI-101, CHEST, Tokyo, Japan). The test was terminated when FEV1 had fallen to a level at least 20% below the baseline measurement. The concentration of MCh required to achieve a MCh PC20 was calculated through linear interpolation of the percentage fall in FEV1 against the log-transformed MCh concentration. 22 
INDUCED SPUTUM
Sputum was induced using the method described by Pin and colleagues. 23 Briefly, after inhaling 200 μg of Salbutamol (GlaxoSmithKline, Tokyo, Japan), subjects inhaled an aerosol of 3%, 4%, and 5% hypertonic saline for 7 min each from an ultrasonic nebulizer (NE-U07, Omron, Tokyo, Japan). After each inhalation period, the subjects expectorated sputum into a container.
The induced sputum was processed as described by Pizzichini and colleagues. 24 The sputum was accepted when total amount of 600 mg and over was obtained in each subject. Briefly, 4 parts 0.1% dithiothreitol (Sputolysin, Calbiochem, CA, USA) was added to 1 part sputum and incubated for 15 min, then 4 parts phosphate-buffered saline (PBS) was added. Total cell counts were determined using a hemocytometer and expressed as the number of cells per milliliter of sputum after trypan-blue staining. Sputum cells were pelleted by centrifugation and the supernatant was removed. The cell pellets were then resuspended in PBS at 0.75 to 1.0 × 10 6 ! ml, and cytospins were prepared using a Shandon III cytocentrifuge (Shandon Southern Instruments, Sewickly, PA, USA). Slides were stained using the May-Giemsa method, and a 1,000 differential cell counts was performed on each slide by a single observer blind to the clinical data; the mean count from two slides per subject was used for analysis. However, data for sputum samples containing >30% epithelial cells and >10% dead cells were not included. The mean frequency (range) of dead cells in asthmatics and controls was 4.1 (0.0 to 8.5%) and 5.2 (1.9 to 8.5%), respectively. Remaining cells were used for flow cytometry.
PERIPHERAL BLOOD
Total white blood cell counts were calculated using a hemocytometer, and differential cell counts were obtained from blood smears using the same method as that for the sputum slides. Cell populations were expressed as the number per milliliter. Peripheral blood mononuclear cells (PBMC) were isolated for flow cytometry on an Accuprep TM (Accurate Chemical and Scientific, Westbury, NY, USA) density gradient. There were >99.9% of live cells of PBMC in both of asthmatics and controls by trypan-blue staining.
FLOW CYTOMETRY
Cells were incubated in 5% normal mouse serum (Sigma) for 10 min, then washed in PBS. This was followed by 5-color and intracellular staining with anti- Briefly, isolated cells were stained with PE-CD152, ECD-CD3, PC5-CD25, PC7-CD4 antibodies, and! or control isotype-matched antibodies. The cells were treated with 1% paraformaldehyde and 0.1% saponin. Then, the cells were further stained with FITC-Foxp3 antibodies, and! or control isotype matched antibodies. A flow cytometer (Cytomics 500, Beckman Coulter) equipped with a 15-mA argon ion laser and filter settings for FITC (525 nm) (FL-1), PE (575 nm) (FL-2), ECD (620 nm) (FL-3), PC5 (675 nm) (FL-4), and PC7 (650 nm) (FL-5) was used. All events were acquired in list mode with debris excluded by the forward scatter threshold. The area of lymphocytes and CD4 + (CD3 + CD4 + ) cells in both induced sputum and peripheral blood after preparation of thresholds to remove the area of debris or dead cells was gated with the forward and side scatter described by Yoshida and coworkers ( Fig. 1a ). 25 The area of CD25 + cells among CD4 + cells was recognized by control isotype matched antibodies. The borderline between CD25 high and CD25 low cells was defined as lying within the area of CD25 + CD4 − CD3 + cells that represented the 1% of the area of CD3 + cells gated along the CD4 and CD25 axis, as CD25 + CD4 − CD3 + cells were low positive for CD25 + (CD25 low ), but not CD25 high CD4 + antigen, in accor-dance with previous reports. 17, 26, 27 The frequency of each subpopulation such as CD25 high and CD25 low cells on CD4 + cells was determined (Fig. 1b) . The frequency of CD25 + cells among CD4 + cells was determined as both the areas of CD25 high and CD25 low cells. Figure 1c shows the area of CTLA4 + , Foxp3 + , and CTLA4 + Foxp3 + cells on panels of PE and FITC axes. The frequency of CTLA4 + cells was calculated as the frequency of CTLA4 + Foxp3 − plus CTLA4 + Foxp3 + cells, and the frequency of Foxp3 + cells was also calculated as the frequency of CTLA4 − Foxp3 + plus CTLA4 + Foxp3 + cells. (Fig. 1d ). Three hundred and over events recognized the CD25 + CD4 + cells were acquired from each sample. The cutoff level for definition of positive cells was less than 2% of cells positively stained with mouse or rat isotype control antibodies (Beckman Coulter). The data were analyzed using the Flow-Jo software package for Windows (Tomy Digital Biology, Tokyo, Japan).
STATISTICAL ANALYSIS
Unless otherwise stated, all results were expressed as the mean ± standard error of the mean (SEM). Values of MCh PC20 were log-transformed prior to analysis and were reported as geometric means ± SEM (GSEM). 22 Paired t-tests were used with correction by Wilcoxon matched-pairs single rank test. Correlations were determined by Spearman's rank correlation test. All comparisons were two-tailed, and p values of <0.05 were considered significant. JMP version 9 for Windows (SAS Institute, Cary, NC, USA) was used for data analysis. 
RESULTS
COMPARISON OF CHARACTERISTICS BE-TWEEN ASTHMATICS AND CONTROLS
All of the asthmatics had atopy and mild asthma (%FEV1 pred. >80%), whereas all of the controls had no respiratory symptoms. As expected by the selection of the subjects, the %FEV1 in asthmatics was significantly lower than that in controls (p = 0.001), and the MCh PC20 values in asthmatics was significantly lower than in controls (p < 0.0001). The absolute number of eosinophils in asthmatics was significantly higher than in controls in both induced sputum and peripheral blood (p < 0.005 and p = 0.0004, respectively) ( Table 1 ). However, there was no significant inter-group difference in the total cell counts or other differential cells counts (data not shown).
CD25 high , CD25 low AND CD25 + CELLS ON CD4 + CELLS IN INDUCED SPUTUM AND PERIPHERAL BLOOD IN ASTHMATICS AND CONTROLS
In both asthmatics and controls, the frequency of CD25 high , CD25 low and CD25 + cells among CD4 + cells in induced sputum was significantly higher than in peripheral blood (p < 0.0001) ( Table 2 ). In peripheral blood, the frequency of CD25 high (p <0.05), but not CD25 low and CD25 + cells among CD4 + cells, was higher in asthmatics than in controls, whereas there was no significant inter-group difference in the frequency of CD25 high , CD25 low and CD25 + cells among CD4 + cells in induced sputum ( Table 2 ).
TREGS AMONG CD25 high AND CD25 low CD4 + CELLS IN INDUCED SPUTUM AND PERIPHERAL BLOOD FROM ASTHMATICS AND CONTROLS
Among CD25 high CD4 + cells in induced sputum, the frequency of CTLA4 + (19.4 ± 2.1%, p = 0.075), Foxp3 + (16.4 ± 3.3%, p = 0.001), and CTLA4 + Foxp3 + (7.0 ± 1.1%, p = 0.008) cells in asthmatics were lower than those in controls (27.2 ± 3.7%, 37.4 ± 4.7%, and 18.2 ± 3.6%, respectively), whereas there was no significant inter-group difference in the frequencies of CTLA4 + (7.1 ± 1.5% vs 5.7 ± 1.7%, p > 0.05), Foxp3 + (35.7 ± 3.2% vs 21.1 ± 3.9%, p > 0.05), and CTLA4 + Foxp3 + (6.6 ± 1.5% vs 4.2 ± 1.0%, p > 0.05) in peripheral blood (Fig. 2  a) . Asthmatics had a higher frequency of CTLA4 + (p = 0.002) cells and a lower frequency of Foxp3 + (p = 0.011) cells, whereas controls had higher frequencies of CTLA4 + (p = 0.001), Foxp3 + (p = 0.024) and CTLA4 + Foxp3 + (p = 0.004) cells in induced sputum than in peripheral blood ( Fig. 2a) (Fig. 2b) . Controls had higher frequencies of CTLA4 + cells (p = 0.003), Foxp3 + (p = 0.087) and CTLA4 + Foxp3 + cells (p = 0.022) in induced sputum than in peripheral blood, whereas asthmatics showed no significant differences in the frequencies of CTLA4 + cells (p > 0.05), Foxp3 + cells (p > 0.05) and CTLA4 + Foxp3 + cells (p > 0.05) between induced sputum and peripheral blood (Fig. 2b) . The frequency of CTLA4 + , Foxp3 + , and CTLA4 + Foxp3 + cells on CD25 high CD4 + cells were significantly higher than that of each cells on CD25 low CD4 + cells in both induced sputum and peripheral blood in asthmatics and controls (all p < 0.05, respectively) ( Fig. 2  a, b) . 
CORRELATIONS BETWEEN TREGS, EOSINO-PHILIC INFLAMMATION, LUNG FUNCTION, AND AHR IN ASTHMATICS
In the asthmatic subjects, the absolute number of sputum eosinophils was significantly correlated with MCh PC20 (r = -0.69, p = 0.007), but not with %FEV1 pred. (r = -0.25, p > 0.05), whereas there was no correlation between peripheral blood eosinophils and MCh PC20 (r = 0.21, p > 0.05) or %FEV1 pred. (r = 0.15, p > 0.05). Among the Treg phenotypes, only CTLA4 + Foxp3 + cells in induced sputum were significantly associated with lung function (%FEV1 pred.) (r = 0.56, p = 0.02) ( Table 3 ).
The frequency of CTAL4 + cells (r = -0.60, p = 0.008), but not Foxp3 + cells (r = -0.25, p > 0.05), in induced sputum among CD25 high CD4 + cells was negatively correlated with the absolute number of sputum eosinophils (Fig. 3) . The frequency of CTLA4 + cells (r = 0.60, p = 0.009), but not Foxp3 + cells (r = -0.00, p > 0.05), among CD25 high CD4 + cells in induced sputum was also correlated with MCh PC20.
The frequencies of CTLA4 + , Foxp3 + and CTLA4 + Foxp3 + cells among CD25 low CD4 + cells in induced sputum were not associated with %FEV1, sputum eosinophils, or MCh PC20. The frequency of CTLA4 + cells among CD25 + CD4 + cells in induced sputum was significantly correlated with MCh PC20 (r = 0.47, p = 0.031), but not with the absolute number of eosino-phils in induced sputum (r = -0.36, p > 0.05) ( Table 3) . There was no significant correlation between the frequency of Tregs in peripheral blood, the absolute number of eosinophils in induced sputum, and the %FEV1 pred. and MCh PC20 (Table 3) .
DISCUSSION
This study has identified that the profiles of three phenotypes of Tregs, namely CTLA4 + CD25 high CD4 + , Foxp 3 + CD 25 high CD 4 + , and CTLA4 + Foxp 3 + CD25 high CD4 + T cells, were significantly decreased in induced sputum from steroid-naïve adult patients with stable, mild atopic asthma in comparison with those in non-atopic healthy subjects.
We have developed a 5-color flow cytometry technique that allowed identification of CTLA4 + , Foxp3 + , and CTLA4 + Foxp3 + on CD25 + CD4 + cells in both induced sputum and peripheral blood. The technique was also able to detect not only CD25 + CD4 + cells, but also CD25 high CD4 + and CD25 low CD4 + cells. CD25 high CD4 + cells were recognized as Tregs, but CD25 low CD4 + cells were activated effector or memory T cells that lack Treg function. 17, 18 In our present study, we found that asthmatics had significantly higher frequencies of CD25 high cells among CD4 + cells in peripheral blood, but not in induced sputum, relative to controls, although there was no significant inter-group difference in the frequency of CD25 low and CD25 + cells among CD4 + cells in induced sputum or peripheral blood. However, the frequencies of CD25 high , CD25 low , and CD25 + cells among CD4 + cells in induced sputum were significantly higher than in peripheral blood in both asthmatics and controls. In asthmatics, there was a significantly negative correlation between the frequency of CTLA4 + cells among CD25 high CD4 + cells in induced sputum and AHR (Fig. 3) . The coefficient of the correlation between CTLA4 + among CD25 high CD4 + cells in induced sputum and AHR was higher than that for CD25 + CD4 + cells and CD25 low CD4 + cells (Table 3) .
Although the present study should ideally have examined both the frequency and absolute number of Tregs (e.g. Foxp3 + CD25 high CD4 + cells) in the induced sputum and peripheral blood of asthmatic patients, CD25 + CD4 + cells were a minor population in induced sputum, as were peripheral CD4 + T cells. The total cell counts in induced sputum obtained from asthmatics varied widely. The absolute numbers of Tregs and CD25 + CD4 + cells were dependent on the total cell counts in induced sputum. Therefore, we determined the frequency of Tregs (e.g. Foxp3 + CD25 high CD4 + cells) in both the induced sputum and peripheral blood of patients with mild asthma. However, we did not evaluate the absolute number of Tregs in the induced sputum and peripheral blood of these patients. Further analysis will be needed to verify this issue.
Expression of Foxp3 molecules by helper T cells is a feature of Tregs. 3, 28 However, the roles of airway Foxp3 + Tregs are still unclear. Smyth and coworkers 15 demonstrated that the frequency of Foxp3 + CD4 + cells in BAL was increased in patients with mild to severe asthma, relative to healthy subjects. However, in the present study, we recognized CTLA4 + and Foxp3 + on CD25 high CD4 + cells as Tregs, and examined induced sputum, as well as selecting patients with mild atopic asthma, not on any treatment. We found that asthmatics had a significantly lower frequency of Foxp 3 + and CTLA 4 + Foxp 3 + cells among CD25 high CD4 + cells in induced sputum than the controls, although there were no significant inter-group differences in the profiles of CTLA4 + , Foxp3 + , or CTLA4 + Foxp3 + cells among CD25 low CD4 + cells in induced sputum and peripheral blood. In asthmatics, the coefficient of correlation between CTLA4 + among CD25 high CD4 + cells in induced sputum and AHR was Fig. 3 Correlation between CTLA4 + and Foxp3 + cells among CD25 high CD4 + cells in induced sputum, eosinophils in induced sputum and AHR in asthmatics. Panels show the correlation between the frequency (%) of CTLA4 + and Foxp3 + cells among CD25 high CD4 + cells in induced sputum, and the absolute number (×10 3 /mL, log) of eosinophils in induced sputum (a) and PC20 MCh (mg/mL) (b) in asthmatics (n = 18). The frequency of CTAL4 + (r = -0.60, p = 0.008), but not Foxp3 + (r = -0.25, p > 0.05) cells, among CD25 high CD4 + cells in induced sputum was negatively associated with the absolute number of eosinophils in induced sputum. The frequency of CTLA4 + (r = 0.60, p = 0.009), but not Foxp3 + (r = -0.00, p > 0.05) cells, among CD25 high CD4 + cells in induced sputum was positively associated with AHR. higher than that of CD25 + CD4 + cells and CD25 low CD4 + cells. In addition, there were obvious differences in the profiles of these phenotypes in induced sputum and peripheral blood between asthmatics and controls. In particular, asthmatics had low and high frequencies of Foxp3 + CD25 high CD4 + cells in the airway and peripheral blood, respectively; whereas in controls, an opposite tendency was observed. Information on the numbers of Tregs in the airway (induced sputum) in asthmatics may be more important than that in the circulating peripheral blood. Our results suggest that airway Foxp3 + CD25 high CD4 + cells, but not CTLA4 + CD25 high CD4 + , cells may be associated with the pathogenesis or development of atopic asthma. Surprisingly, the frequency of CTLA4 + , but not Foxp 3 + and CTLA 4 + Foxp 3 + cells, among CD25 high CD4 + cells in induced sputum was associated with AHR in asthmatics. A low frequency of CTLA4 + cells among CD25 high CD4 + cells was also associated with airway eosinophilic inflammation. CTLA4 is a potent T-cell down-regulatory molecule expressed by naturally occurring Tregs during peripheral immune responses. Polymorphism of the CTLA4 gene may be associated with AHR and disease severity in asthma. 24, 29 Thus, these results suggest that airway CTLA4 + CD25 high CD4 + cells may play a role in atopic asthma, modifying features such as airway eosinophilic inflammation and AHR.
CTLA4 is required for the function of Foxp3expressing Tregs. 25, 30 The CTLA4 and Foxp3 molecules of Tregs mutually control the function of the other. 26, 31 CTLA4 expression on natural occurring Foxp3 + Tregs may reveal opposing effects of costimulation modulators on the steady-state level and quality of Tregs. 27, 32 Interaction between airway CTLA4 and Foxp3 protein expression on CD25 high CD4 + cells is also marked in asthmatics. Here we found that airway CTLA4 + Foxp3 + cells, but not CTLA4 + and Foxp3 + , cells were associated with %FEV1 pred. in asthmatics.
It is known that glucocorticosteroids enhance the expression of Foxp3 protein on CD25 high CD4 + cells in asthmatics. 10, 13, 28, 33 We previously demonstrated that inhaled corticosteroids increased sputum CTLA4 + CD25 + CD4 + cells, along with an increase in the level of IL-10 in patients with mild asthma. 9,14 CD80! CD86 molecules enhance the expression of CTLA4. 29, 30, 34, 35 Immunotherapy against specific allergens has also been shown to significantly increase Foxp3 + Tregs cells, with the presence of IL-10 and TGF-beta, leading to improvement of asthma control and quality of life in allergic subjects. 31, 36 Enhancement of airway CTLA4 and Foxp3 molecules on T cells may contribute to asthma control. 32, 37 On the basis of the known data, therefore, in the present study we carefully excluded asthmatics that were using inhaled corticosteroids.
In summary, the present findings suggest that it would be better to define CD25 high CD4 + cells as Tregs, rather than CD25 low or CD25 + CD4 + cells, in patients with atopic asthma. Information on airway Tregs in asthmatics is more relevant than that for circulating Tregs, not only. Airway CTLA4 + Tregs appear to contribute to airway eosinophilic inflammation and AHR.
